Knockdown of NPTX1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells.
- Author:
Ting SHUAI
1
;
Yanyan GUO
1
;
Chunping LIN
2
;
Xiaomei HOU
1
;
Chanyuan JIN
1
Author Information
1. Second Clinical Division, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digi-tal Medical Devices & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China.
2. Department of Stomatology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou 350001, China.
- Publication Type:Journal Article
- Keywords:
Bone marrow mesenchymal stem cells;
NPTX1 gene;
Osteogenic differentiation
- MeSH:
Humans;
Mesenchymal Stem Cells/cytology*;
Osteogenesis/genetics*;
Cell Differentiation/genetics*;
Nerve Tissue Proteins/genetics*;
Cells, Cultured;
C-Reactive Protein/genetics*;
RNA, Small Interfering/genetics*;
Core Binding Factor Alpha 1 Subunit/metabolism*;
Bone Marrow Cells/cytology*;
Gene Knockdown Techniques;
Osteocalcin/metabolism*;
Alkaline Phosphatase/metabolism*;
RNA, Messenger/metabolism*
- From:
Journal of Peking University(Health Sciences)
2025;57(1):7-12
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To initially investigate the function of neuronal pentraxin 1 (NPTX1) gene on osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMSCs).
METHODS:hBMSCs were induced to undergo osteogenic differentiation, and then RNA was collected at different time points, namely 0, 3, 7, 10 and 14 d. The mRNA expression levels of key genes related with osteogenic differentiation, including runt-related transcription factor 2 (RUNX2), alkaline phosphatase (ALP), osteocalcin (OCN), and NPTX1, were detected on the basis of quantitative real-time polymerase chain reaction (qPCR) technology. In order to establish a stable NPTX1-knockdown hBMSCs cell line, NPTX1 shRNA lentivirus was constructed and used to infect hBMSCs. ALP staining, alizarin red (AR) staining, and qPCR were employed to assess the impact of NPTX1-knockdown on the osteogenic differentiation ability of hBMSCs.
RESULTS:The results showed that during the osteogenic differentiation of hBMSCs in vitro, the mRNA expression levels of osteogenic genes RUNX2, ALP and OCN significantly increased compared with 0 d, while NPTX1 expression decreased markedly (P < 0.01) as the osteogenic induction period exten-ded. At 72 h post-infection with lentivirus, the result of qPCR indicated that the knockdown efficiency of NPTX1 was over 60%. After knocking down NPTX1 in hBMSCs, RNA was extracted from both the NPTX1-knockdown group (sh NPTX1 group) and the control group (shNC group) cultured in regular proliferation medium. The results of qPCR showed that the expression levels of osteogenic-related genes RUNX2 and osterix (OSX) were significantly higher in the sh NPTX1 group compared with the shNC group (P < 0.01). ALP staining revealed a significantly deeper coloration in the sh NPTX1 group than in the shNC group at the end of 7 d of osteogenic induction. AR staining demonstrated a marked increase in mineralized nodules in the sh NPTX1 group compared with the shNC group at the end of 14 d of osteogenic induction.
CONCLUSION:NPTX1 exerts a modulatory role in the osteogenic differentiation of hBMSCs, and its knockdown has been found to enhance the osteogenic differentiation of hBMSCs. This finding implies that NPTX1 could potentially serve as a therapeutic target for the treatment of osteogenic abnormalities, including osteoporosis.
